Transsphincteric Fistula Management Using LIFT and MAF
Launched by ZAGAZIG UNIVERSITY · Sep 25, 2024
Trial Information
Current as of July 01, 2025
Completed
Keywords
ClinConnect Summary
we compared between LIFT and MAF in elderly with PAF
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • elderly persons with PAF
- Exclusion Criteria:
- • recurrent fistula
- • associated autoimmune diseases
About Zagazig University
Zagazig University, a prominent educational and research institution located in Egypt, plays a pivotal role in advancing medical knowledge and promoting health innovations through its clinical trials. With a commitment to excellence in research, the university leverages its diverse expertise and state-of-the-art facilities to conduct rigorous clinical studies that aim to improve patient care and outcomes. By fostering collaboration among multidisciplinary teams, Zagazig University contributes significantly to the global medical community, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zagazig, Sharkia, Egypt
Patients applied
Trial Officials
Tamer. A.A.M. Habeeb
Principal Investigator
Zagazig University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported